Retrospective analysis of primary tissues from NSCLC patients showed marked reduction in PKR and OAS as the disease advanced, corroborating the pivotal roles of PKR and OAS in suppressing lung cancer. This evidence concerns the gene EIF2AK2 and lung cancer.